Rchr
J-GLOBAL ID:201401026630114907   Update date: Aug. 30, 2021

Sawada Takeshi

Sawada Takeshi
Research field  (1): Tumor diagnostics and therapeutics
Papers (23):
  • Kaname Nosaki, Hideo Saka, Yukio Hosomi, Paul Baas, Gilberto de Castro Jr, Martin Reck, Yi-Long Wu, Julie R Brahmer, Enriqueta Felip, Takeshi Sawada, et al. Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies. Lung cancer (Amsterdam, Netherlands). 2019. 135. 188-195
  • Takeshi Sawada, Riet Hilhorst, Savithri Rangarajan, Masayuki Yoshida, Yuko Tanabe, Kenji Tamura, Takayuki Kinoshita, Tatsu Shimoyama, Rinie van Beuningen, Rob Ruijtenbeek, et al. Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles. Oncotarget. 2018. 9. 76. 34229-34239
  • Shun-Ichiro Kageyama, Keiji Nihei, Katsuyuki Karasawa, Takeshi Sawada, Fumiaki Koizumi, Shigeo Yamaguchi, Shunsuke Kato, Hidehiro Hojo, Atsushi Motegi, Katsuya Tsuchihara, et al. Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients. Oncotarget. 2018. 9. 34. 23844-23844
  • Shun-Ichiro Kageyama, Keiji Nihei, Katsuyuki Karasawa, Takeshi Sawada, Fumiaki Koizumi, Shigeo Yamaguchi, Shunsuke Kato, Hidehiro Hojo, Atsuhi Motegi, Katsuya Tsuchihara, et al. Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients. Oncotarget. 2018. 9. 27. 19368-19378
  • Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda. Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients. Hematological oncology. 2018. 36. 1. 76-83
more...
MISC (47):
  • Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda. Prognostic significance of CD30 expression in patients with diffuse large B-cell lymphoma. ANNALS OF ONCOLOGY. 2017. 28
  • Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Ryoko Sekiya, Naoki Yanagisawa, Akifumi Imamura, Tsunekazu Hishima, et al. Outcome Analysis of DLBCL in HIV-infected and non-HIV-infected patients. ANNALS OF ONCOLOGY. 2016. 27
  • Yuta Ishiyama, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yusuke Kanemasa, Yasushi Omuro, Yoshiharu Maeda. Study of Pneumocystis Pneumonia of Trimethoprim/Sulfamethoxazole in NHL patients receiving R-CHOP regimen. ANNALS OF ONCOLOGY. 2016. 27
  • Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Sawada Takeshi, Eisaku Sasaki, Yasushi Omuro, Yoshiharu Maeda, Tsunekazu Hishima, Tsuneo Sasaki. Central nervous system relapse in diffuse large B-cell lymphoma: analysis of risk factors and a new prognostic model. ANNALS OF ONCOLOGY. 2015. 26. 85-86
  • Tsukasa Yamaguchi, Yusuke Kanemasa, Takeshi Sawada, Tatsu Shimoyama, Eisaku Sasaki, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda, Tsuneo Sasaki. Beta-2 microglobulin as a significant prognostic factor and a new risk model for diffuse large B-Cell lymphoma. ANNALS OF ONCOLOGY. 2015. 26. 97-97
more...
Lectures and oral presentations  (18):
  • Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1-positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042
    (ESMO selected BEST Abstract plenary session 2019)
  • Immune system pathway activation for prediction of the response to neoadjuvant chemotherapy in triple negative breast cancer
    (2017)
  • Mutational analysis of primary tumors and single circulating tumor cells captured by a novel dielectrophoretic microwell array system in metastatic lung cancer, oral cancer and breast cancer patients
    (The 28th EORTC-NCI-AACR symposium 2016)
  • Developing Circulating Tumor Cell Detection Systems
    (The 1st Circulating Tumor Cell Forum 2016 2016)
  • Identification of a novel compound, MO2455, that induces poly(ADP-ribose) (PAR) accumulation and inhibits the growth of cancer cells in vitro and in vivo
    (American Association for Cancer Research Annual Meeting 2016 2016)
more...
Education (2):
  • 2012 - 2016 神戸大学大学院 血液・腫瘍内科専攻 博士課程
  • 2001 - 2007 Kobe University Faculty of Medicine
Professional career (1):
  • Doctor of Medical Science (Kobe University)
Work history (7):
  • 2020/02 - 2021/03 MSD K.K Oncology Science Unit, Oncology Scientific Affairs Director
  • 2017/01 - 2020/01 MSD K.K Oncology Science Unit, Oncology Science Affairs Associate Director
  • 2014/04 - 2016/12 日本医療研究開発機構(AMED) がん研究課 リサーチレジデント
  • 2014/04 - 2016/12 がん感染症センター都立駒込病院 腫瘍内科 非常勤医員
  • 2012/04 - 2014/03 National Cancer Center
Show all
Awards (4):
  • 2016/11 - Official travel grant, the 28th EORTC-NCI-AACR symposium
  • 2014/11 - Travel Grant, the 26th EORTC-NCI-AACR symposium
  • 2014/04 - 日本医療研究開発機構(AMED) Awardee of Research Resident Fellowship
  • 2012/04 - Awardee of Research Resident Fellowship for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control
Association Membership(s) (3):
日本臨床薬理学会 ,  日本がん分子標的治療学会 ,  日本血液学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page